Clinical Trials Logo

Mannitol Adverse Reaction clinical trials

View clinical trials related to Mannitol Adverse Reaction.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04251689 Completed - Clinical trials for Mannitol Adverse Reaction

The Effect of Intravenous Mannitol Plus Saline on the Prevention of Cisplatin-induced Nephrotoxicity: A Randomized, Double-blind, Placebo Controlled Trial

MACIN
Start date: December 1, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

This study include cancer patients who had received chemotherapy that include cisplatin. Patients were randomly assigned to either a mannitol 20 g intravenous single dose after cisplatin or a placebo (saline). The primary outcome was to compare acute kidney injury (AKI), which was defined as increase creatinine 0.3 mg/dl in 48 hours by KDIGO criteria using serum creatinine and 24 hour urine creatinine to calculated.

NCT ID: NCT03161977 Completed - Hyperkalemia Clinical Trials

The Effect of Mannitol on the Serum Potassium During Craniotomy

Start date: January 1, 2017
Phase: N/A
Study type: Observational

This is an observational study designed to research the effect of mannitol on the concentration of intraoperative serum potassium in patients undergoing craniotomy, and to guide the safe use of mannitol during craniotomy.